Szeretne többet megtudni szolgáltasainkról?
Töltse ki az alábbi regisztrációs felületet és kollégáink hamarosan felveszik önnel a kapcsolatot, hogy válaszoljanak minden felmerülő kérdésére
A Famicord csoport laboratóriumaiból kezelésre kiadott minták listája.
| Lp. |
Őssejt forrás |
Forrás típusa |
Diagnózis |
Érintett szakterület |
Kezelés éve |
Terápia |
Ország |
Páciens életkora |
| 7201 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2017
|
Standard Therapy |
Poland |
72 |
| 7202 |
Apheresis |
Allogeneic
|
Chronic Myelomonocytic Leukemia
|
Hematology
|
2017
|
Standard Therapy |
Poland |
60 |
| 7203 |
Apheresis |
Allogeneic
|
Chronic Myeloproliferative Neoplasm Blast Crisis
|
Hematology
|
2017
|
Standard Therapy |
Poland |
29 |
| 7204 |
Apheresis |
Allogeneic
|
Common Variable Immunodeficiency, Relapsed Hemophagocytic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
44 |
| 7205 |
Apheresis |
Allogeneic
|
Diffuse Large B-Cell Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Poland |
61 |
| 7206 |
Apheresis |
Allogeneic
|
Diffuse Large B-Cell Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
41 |
| 7207 |
Apheresis |
Autologous
|
Diffuse Large B-Cell Lymphoma – Relapse
|
Hematology
|
2017
|
Standard Therapy |
Germany |
67 |
| 7208 |
Apheresis |
Autologous
|
Follicular B-Cell Non-Hodgkin-Lymphoma Grade I-II Relapse
|
Hematology
|
2017
|
Standard Therapy |
Germany |
59 |
| 7209 |
Apheresis |
Allogeneic
|
Follicular Ca
|
Hematology
|
2017
|
Standard Therapy |
Poland |
42 |
| 7210 |
Apheresis |
Autologous
|
Follicular Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
47 |
| 7211 |
Apheresis |
Allogeneic
|
Hemophagocytosis
|
Hematology
|
2017
|
Standard Therapy |
Poland |
52 |
| 7212 |
Apheresis |
Allogeneic
|
Hodgkin Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Poland |
25 |
| 7213 |
Apheresis |
Allogeneic
|
Langerhans Lymphohistiocytosis
|
Hematology
|
2017
|
Standard Therapy |
Poland |
2 |
| 7214 |
Apheresis |
Autologous
|
Light-Chain Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
62 |
| 7215 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
58 |
| 7216 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
63 |
| 7217 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
61 |
| 7218 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
64 |
| 7219 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
59 |
| 7220 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
68 |
| 7221 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
50 |
| 7222 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
56 |
| 7223 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
62 |
| 7224 |
Apheresis |
Autologous
|
Mantle Cell Lymphoma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
53 |
| 7225 |
Apheresis |
Allogeneic
|
Morbus Hodgkin
|
Hematology
|
2017
|
Standard Therapy |
Germany |
38 |
| 7226 |
Apheresis |
Autologous
|
Morbus Hodgkin
|
Hematology
|
2017
|
Standard Therapy |
Germany |
60 |
| 7227 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
61 |
| 7228 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
65 |
| 7229 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
64 |
| 7230 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
61 |
| 7231 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
60 |
| 7232 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
58 |
| 7233 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
61 |
| 7234 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
63 |
| 7235 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
58 |
| 7236 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
72 |
| 7237 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
63 |
| 7238 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
50 |
| 7239 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
52 |
| 7240 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
72 |
| 7241 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
57 |
| 7242 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
56 |
| 7243 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
59 |
| 7244 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
64 |
| 7245 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
72 |
| 7246 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
69 |
| 7247 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
52 |
| 7248 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
67 |
| 7249 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
64 |
| 7250 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
64 |
| 7251 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
50 |
| 7252 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
67 |
| 7253 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
53 |
| 7254 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
62 |
| 7255 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
44 |
| 7256 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
62 |
| 7257 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
56 |
| 7258 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
60 |
| 7259 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
64 |
| 7260 |
Apheresis |
Autologous
|
Multiple Myeloma
|
Hematology
|
2017
|
Standard Therapy |
Germany |
64 |
| 7261 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
60 |
| 7262 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
3 |
| 7263 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
56 |
| 7264 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
54 |
| 7265 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
75 |
| 7266 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
64 |
| 7267 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
64 |
| 7268 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
46 |
| 7269 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
53 |
| 7270 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
71 |
| 7271 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
50 |
| 7272 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
63 |
| 7273 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
67 |
| 7274 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
65 |
| 7275 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
68 |
| 7276 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
59 |
| 7277 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
63 |
| 7278 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
69 |
| 7279 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
54 |
| 7280 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
65 |
| 7281 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
63 |
| 7282 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
54 |
| 7283 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
49 |
| 7284 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
39 |
| 7285 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
67 |
| 7286 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
69 |
| 7287 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
76 |
| 7288 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
70 |
| 7289 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
53 |
| 7290 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
69 |
| 7291 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
63 |
| 7292 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
66 |
| 7293 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
68 |
| 7294 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
63 |
| 7295 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
61 |
| 7296 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
61 |
| 7297 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
22 |
| 7298 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
40 |
| 7299 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
57 |
| 7300 |
Apheresis |
Allogeneic
|
Myelodysplastic Syndrome
|
Hematology
|
2017
|
Standard Therapy |
Poland |
63 |